A phase 1, open label, dose seeking study of AZD2171 given daily orally in combination with selected chemotherapy regimens in patients with advanced incurable non-small cell lung cancer or colorectal cancer
Study identifier:D8480C00022
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A phase 1, open label, dose seeking study of AZD2171 given daily orally in combination with selected chemotherapy regimens in patients with advanced incurable non-small cell lung cancer or colorectal cancer
Medical condition
Oncology
Phase
Phase 2
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Nov 2005
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
